Live Breaking News & Updates on Morphic Investor

Stay updated with breaking news from Morphic investor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Morphic Announces Corporate Highlights and Financial

-Reported positive topline results from EMERALD-1 study of MORF-057 in ulcerative colitis- -Continued enrollment on target in EMERALD-2 Phase 2b trial. ....

United States , Chris Erdman , Praveen Tipirneni , Canaccord Genuity , Development Program Updates , Securities Exchange , Morphic Holding Inc , Exchange Commission , Chief Executive Officer , Recent Corporate Highlights , Robarts Histopathology Index , Modified Mayo Clinic Score , Digestive Disease Week , Second Quarter , Morphic Investor , Medical Meeting , Annual Growth Conference , Fargo Healthcare Conference , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Financial Tables , Consolidated Statements , Months Ended June ,